β-Nicotinamide adenine dinucleotide, reduced dipotassium salt
SIGMA/N4505
Synonym: β-DPNH; β-NADH; DPNH; Diphosphopyridine nucleotide, reduced form; NADH
CAS Number: 104809-32-7
Empirical Formula (Hill Notation): C21H27K2N7O14P2
Molecular Weight: 741.62
MDL Number: MFCD00079494
Linear Formula: C21H27N7O14P2K2
Product Type: Chemical
| assay | ≥95% |
| biological source | synthetic |
| form | powder |
| InChI | 1S/C21H29N7O14P2.K.H/c22- |
| InChI key | KMRPNNQOKAHXEZ-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | [K].NC(=O)C1=CN(C=CC1)C2O |
| solubility | 10 mM NaOH: soluble-100 mg/mL, clear to hazy, faintly yellow to yellow |
| storage temp. | −20°C |
| Application: | β-Nicotinamide adenine dinucleotide (NAD+) and β-Nicotinamide adenine dinucleotide, reduced (NADH) comprise a coenzyme redox pair (NAD+:NADH) involved in a wide range of enzyme catalyzed oxidation reduction reactions. In addition to its redox function, NAD+/NADH is a donor of ADP-ribose units in ADP-ribosylaton (ADP-ribosyltransferases; poly(ADP-ribose) polymerases ) reactions and a precursor of cyclic ADP-ribose (ADP-ribosyl cyclases). |
| Biochem/physiol Actions: | Electron donor |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research ![]() |
| Packaging: | 1 g in poly bottle |
| Packaging: | 100, 500 mg in poly bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% |
| Storage Temp. | −20°C |
| UNSPSC | 41106305 |

